• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/16/2018
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi)#: (b)(4).
 
Event Description
The patient's son stated they received questionable results from coaguchek xs meter serial number (b)(4).They used strip lots 27216421 and 25863822 on both dates of testing.He could not specify which lot gave which results.The medwatchs involved in this event include patient identifiers (b)(6).On (b)(6) 2018, within 30 minutes the results from two different fingers were 2.3 inr, >8.0 inr, and 1.6 inr.He stated the patient ate some brussel sprouts in between the tests.No changes were made in the warfarin dose due to the results.On (b)(6) 2018, the patient performed three tests within less than 10 minutes and the results were 2.3 inr, 1.8 inr and 1.9 inr.The patient's son reported the result of 2.3 inr.There was no allegation of an adverse event.There were no recent changes in health or other medications, no other blood thinners except warfarin and baby aspirin.The patient had no direct thrombin inhibitors, no lupus, no antiphospholipid antibodies, and no concerns with hematocrit levels.The patient had no signs of high inr.The therapeutic range was 2.0-3.0 inr.The suspect meter and strips were requested to be returned for investigation.Relevant retention test strips (lot 272164) were tested in comparison with the master lot coaguchek xs pt.For this purpose, two human blood samples from marcumar donors and two internal reference meters were used.No error messages occurred.Retention samples were acceptable and retention material performed as specified.
 
Manufacturer Narrative
The customer meter and strips were returned for investigation.The returned meter and strips were tested in comparison to a retention meter and masterlot strips.Human blood samples from warfarin donors were used.Donor 1 inr: 2.4 inr, donor 2 inr: 2.8 inr.Donor 1 hct: 47%, donor 2 hct: 38%.Testing results: donor 1: retention meter with masterlot strips: 2.4 inr, customer meter with customer strips: 2.4 inr.Donor 2: retention meter with masterlot strips: 2.8 inr, customer meter with customer strips: 2.7 inr.All inr values were within the specified maximum difference between measurements.No error messages occurred.The returned and the retention material meet the specifications.Customer stated that they not always apply the sample within 15 seconds.Per product labeling blood should be applied within 15 seconds of the fingerstick.The results alleged by the customer were observed in the meter¿s patient result memory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7479349
MDR Text Key107825936
Report Number1823260-2018-01320
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 05/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2019
Device Catalogue Number04625374160
Device Lot Number27216421
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/03/2018
Initial Date Manufacturer Received 04/17/2018
Initial Date FDA Received05/02/2018
Supplement Dates Manufacturer Received04/17/2018
Supplement Dates FDA Received05/17/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
"BLOOD PRESSURE PILLS"; "CHOLESTEROL PILLS"; "WATER PILLS"; ASPIRIN; WARFARIN
Patient Age82 YR
Patient Weight73
-
-